The KNSTRN Knockout A-549 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population derived from the A-549 human lung adenocarcinoma cell line, carrying a targeted disruption of the KNSTRN gene. This loss-of-function model abolishes KNSTRN protein expression, providing a robust tool for functional studies of this essential kinetochore-associated factor in a physiologically relevant epithelial cancer background.
The A-549 cell line, originally isolated from a human lung adenocarcinoma, is a well-established model for non-small cell lung cancer (NSCLC). These epithelial cells display hallmark features of lung adenocarcinoma and have been extensively used to investigate oncogenic signaling, drug sensitivity, and tumor biology. Their established utility in mitotic research and chromosomal instability studies makes them an ideal host for dissecting KNSTRN function within the context of lung cancer pathology.
KNSTRN encodes a kinetochore-associated protein that directly interacts with astrin (SPAG5), SKAP, CLASP1, CLASP2, and BUB1B to stabilize kinetochore-microtubule attachments and ensure faithful chromosome alignment during mitosis. The protein operates downstream of key mitotic regulators including CDK1, Aurora kinase B, PLK1, CENP-E, and dynein, and its activity facilitates silencing of the spindle assembly checkpoint by promoting correct attachment. Consequently, loss of KNSTRN disrupts the recruitment and function of downstream effectors such as astrin, SKAP, and the APC/C complex, leading to prolonged checkpoint activation and mitotic delay.
In A-549 lung adenocarcinoma cells, disruption of KNSTRN is expected to impair mitotic progression, manifesting as chromosome misalignment, lagging chromosomes, and an elevated mitotic index. This aberrant mitosis can drive chromosomal instability, a hallmark of many cancers, and may sensitize cells to anti-mitotic chemotherapeutics. Thus, the KNSTRN knockout A-549 polyclonal population offers a valuable platform for exploring mechanistic links between kinetochore dysfunction, chromosomal instability, and lung cancer pathogenesis, as well as for evaluating therapeutic vulnerabilities associated with mitotic checkpoint defects.
Researchers can employ this knockout model in a variety of functional assays, including high-content live-cell mitotic imaging to monitor chromosome dynamics and mitotic progression, immunofluorescence staining of mitotic structures such as kinetochores and spindle microtubules, and flow cytometric cell cycle analysis to quantify mitotic populations using phospho-histone H3 staining. Additional applications encompass chromosome spread analysis to assess numerical and structural aberrations, clonogenic survival assays to probe drug sensitivity, and Annexin V apoptosis assays to measure cell death upon mitotic stress. For further information or to discuss custom cell engineering projects, please contact Ascent Research.
